{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreighywkawmpo4ku52hgkzel4vkqqljlof4ypinaozlzrhyn3bfeohu",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mjqg52zonih2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreihs4yniv5gslv4xxwpwazmdqvpsj3sble4olz6hvbzdguafle3ihy"
    },
    "mimeType": "image/jpeg",
    "size": 123080
  },
  "path": "/pharmalot/2026/04/17/lilly-weight-loss-pill-results-uk-slashing-clinical-trial-times/?utm_campaign=rss",
  "publishedAt": "2026-04-17T13:07:51.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Pharma",
    "Pharmalot",
    "pharmalittle",
    "STAT"
  ],
  "textContent": "Scientists whose work led to powerful obesity drugs like Zepbound are now suggesting targeting the GLP-1 hormone is not necessary for effective weight loss",
  "title": "STAT+: Pharmalittle: We’re reading about Lilly weight loss pill trial results, slashed U.K. clinical trial times, and more",
  "updatedAt": "2026-04-17T13:08:01.000Z"
}